KaydedilenlerDerginizi ekleyin

Dergiler / Tüberküloz ve Toraks / 2021 / Cilt: 69 - Sayı: 4

Current situation in ARDS in the light of recent studies: Classification, epidemiology and pharmacotherapeutics

Güncel çalışmalar ışığında ARDS’de mevcut durum: Sınıflandırma, epidemiyoloji ve farmakoterapötikler

Fatma YILDIRIM
İrem KARAMAN
Akın KAYA
Sayfa
535–546
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In this review, current changes in the definition and epidemiology of ARDS, recent pharmacotherapeutic research and mesenchymal stem cell therapies will be discussed in the light of newly introduced ARDS phenotypes.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Current situation in ARDS in the light of recent studies: Classification, epidemiology and pharmacotherapeutics In the last 50 years, there have been great research and developments in the definition and pathophysiology of acute respiratory distress syndrome (ARDS), the most progressive form of acute hypoxemic respiratory failure.
📊
Temel Bulgular & Veri:Although there are various discussions and recommendations, the definition of ARDS is still based on the Berlin 2012 diagnostic criteria.
💡
Sonuç & Katkı:In this review, current changes in the definition and epidemiology of ARDS, recent pharmacotherapeutic research and mesenchymal stem cell therapies will be discussed in the light of newly introduced ARDS phenotypes.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2012 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Current situation in ARDS in the light of recent studies: Classification, epidemiology and pharmacotherapeutics In the last 50 years, there have been great research and developments in the definition and pathophysiology of acute respiratory distress syndrome (ARDS), the most progressive form of acute hypoxemic respiratory failure. Although there are various discussions and recommendations, the definition of ARDS is still based on the Berlin 2012 diagnostic criteria. Despite various studies in recent years, there is still no effective pharmacotherapeutic agent for the treatment of ARDS. Lung protective mechanical ventilation (low tidal volume, low plateau pressure, low driving pressure) in all ARDS patients, prone position, neuromuscular blockade (cisatracurium) in moderate-severe ARDS patients, and hydrocortisone therapy in sepsis-associated ARDS patients are treatments that contribute to survival. In this review, current changes in the definition and epidemiology of ARDS, recent pharmacotherapeutic research and mesenchymal stem cell therapies will be discussed in the light of newly introduced ARDS phenotypes.

Abstract

Akut hipoksemik solunum yetmezliğinin en progresif formu olan akut solunum sıkıntısı sendromunun (ARDS) tanımı ve patofizyolojisi konusunda son 50 yılda büyük araştırmalar ve gelişmeler olmuştur. ARDS tanımı halen üzerinde çeşitli tartışma ve öneriler olmasına rağmen Berlin 2012 tanı kriterlerine dayanmaktadır. Son yıllardaki çeşitli araştırmalara rağmen ARDS tedavisinde etkin bir farmakoterapötik ajan halen bulunmamaktadır. Tüm ARDS hastalarında akciğer koruyucu mekanik ventilasyon (düşük tidal volüm, düşük plato basıncı, düşük sürücü basınç); orta-ağır ARDS hastalarında pron pozisyon, nöromüskuler blökor (sisatraküryum) ve sepsis ilişkili ARDS hastalarında hidrokortizon tedavisi sağkalıma fayda sağlayan tedavilerdir. Bu derlemede ARDS tanımındaki ve epidemiyolojisindeki günümüze kadar olan değişiklikler, tedavideki farmakoterapötik son araştırmalar ve mezenkimal kök hücre tedavileri yeni ortaya atılan ARDS fenotipleri eşliğinde tartışılacaktır.

🔖

Bu Makaleye Atıf Yap

YILDIRIM, F., KARAMAN, İ., KAYA, A. (2021). Current situation in ARDS in the light of recent studies: Classification, epidemiology and pharmacotherapeutics. Tüberküloz ve Toraks, Cilt: 69 - Sayı: 4, 535–546. https://ajindex.com/articles/418832

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967; 2(7511): 319- 23
  2. Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138(3): 720-3
  3. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L. et al. The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149(3 Pt 1): 818-24
  4. ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E. et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012; 307(23): 2526-33
  5. Riviello ED, Kiviri W, Twagirumugabe T, Mueller A, BannerGoodspeed VM, Officer L. et al. Hospital incidence and outcomes of the acute respiratory distress syndrome using the kigali modification of the Berlin definition. Am J Respir Crit Care Med 2016; 193(1): 52-9
  6. Matthay MA, Thompson BT, Ware LB. The Berlin definition of acute respiratory distress syndrome: Should patients receiving high-flow nasal oxygen be included? Lancet Respir Med 2021; 9(8): 933-6 7. Warren MA, Zhao Z, Koyama T, Bastarache JA, Shaver CM, Semler MW, et al. Severity scoring of lung oedema on the chest radiograph is associated with clinical outcomes in ARDS. Thorax 2018; 73(9): 840-6
  7. Bhattarai S, Gupta A, Ali E, Ali M, Riad M, Adhikari P, et al. Can big data and machine learning improve our understanding of acute respiratory distress syndrome? Cureus 2021; 13(2): e13529
  8. Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016; 315(8): 788- 800
  9. McNicholas BA, Rooney GM, Laffey JG. Lessons to learn from epidemiologic studies in ARDS. Curr Opin Crit Care 2018; 24(1): 41-48
  10. Sakr Y, François B, Solé-Violan J, Kotfis K, Jaschinski U, Estella A, et al. Temporal changes in the epidemiology, management, and outcome from acute respiratory distress syndrome in European intensive care units: a comparison of two large cohorts. Crit Care 2021; 25(1): 87
  11. Gajic O, Dabbagh O, Park PK, Adesanya A, Chang SY, Hou P, et al. Early identification of patients at risk of acute lung injury: Evaluation of lung injury prediction score in a multicenter cohort study. Am J Respir Crit Care Med 2011; 183(4): 462-70
  12. Neto AS